Collaboration with Quadram Institute Bioscience Will Focus on New Therapies for Immune-Related Conditions DuPont Nutrition and Biosciences announced a 3-year project to study gut bacteria's influence the immune system. The company is partnering with Quadram Institute Bioscience (QIB) to complete the focus. The research will evaluate how extracellular vesicles (EVs), which are naturally produced by the
DermBiont, a clinical stage therapeutics company dedicated to the discovery and development of live bacterial products for the treatment of skin diseases has closed an $8M Series A. The funding round was led by Zola Global Investors, Toba Capital, and Viking Global Investors. The financing proceeds will be used to fund ongoing clinical trials and
New solutions on the horizon to fight infection It is estimated that superbugs, antibiotic-resistant bacteria, will kill 10 million people annually by the year 2050, costing the global economy $100 trillion. Today, in 2018, 2 million people in the United States alone are infected by superbugs each year, 23,000 of them losing their life. We
A Webinar By Labroots on New Studies To Combat Infectious Disease Natural flora is impacted by sickness. Natural flora is the healthy bacteria on/in our bodies that protect us from the bad ones. More studies are being done to discover and learn more about microbiome, the full DNA makeup of our bodies, from the inside
Can your fingerprint germs solve crimes? A look into microbiome science and the studies of the germs living on your skin and in your gut.
What you need to know about Bacteria It is estimated there at over 5,000,000,000,000,000,000,000,000,000,000 variations of bacteria living on this earth. CBS Sunday Morning Anchor, Jane Pauley, reported on the the discovery of bacteria Sunday, September 17, 2017 during the weekly almanac story. Bacteria was first discovered in human dental plaque by Dutch Scientist Antonie